Nika Pharmaceuticals, Inc. (NIKA)

Nika Pharmaceuticals Statistics

Total Valuation

Nika Pharmaceuticals has a market cap or net worth of 516.61 million. The enterprise value is 516.82 million.

Market Cap	516.61M
Enterprise Value	516.82M

Important Dates

The next estimated earnings date is Wednesday, March 12, 2025.

Earnings Date	Mar 12, 2025
Ex-Dividend Date	n/a

Share Statistics

Nika Pharmaceuticals has 1.02 billion shares outstanding. The number of shares has increased by 3.03% in one year.

Current Share Class	n/a
Shares Outstanding	1.02B
Shares Change (YoY)	+3.03%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	48.27%
Owned by Institutions (%)	15.17%
Float	376.90M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-5,701.12
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.01

Current Ratio	0.01
Quick Ratio	0.01
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-921.57%
Return on Capital (ROIC)	-921.57%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	24.51
Average Volume (20 Days)	2,998

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	0.11

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-90,653
Pretax Income	-90,653
Net Income	-90,653
EBITDA	n/a
EBIT	-90,653
Earnings Per Share (EPS)	-0.00

Balance Sheet

The company has 1,386 in cash and 210,164 in debt, giving a net cash position of -208,778 or -0.00 per share.

Cash & Cash Equivalents	1,386
Total Debt	210,164
Net Cash	-208,778
Net Cash Per Share	-0.00
Equity (Book Value)	-208,778
Book Value Per Share	-0.00
Working Capital	-208,778

Cash Flow

Operating Cash Flow	-133,943
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Nika Pharmaceuticals does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.03%
Shareholder Yield	-3.03%
Earnings Yield	-0.02%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a